longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Strive

ASST

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is -2.01, within the reasonable range, cheaper than 64.8% of the time in the past 3 years, and the industry ranks 97/175, the industry Median -0.88.

-2.01xP/E
$28.28Stock price
$-14.10Earnings per share
-2.01xP/E
Stock price$28.28Earnings per share$-14.10

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
-1.44x
Typical range
-3.23x–-0.98x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
011223344

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
BAXUSBaxter
-11.20x141.71%$11.90B
GKOSUSGlaukos
-50.63x75.34%$9.52B
TFXUSTeleflex
-5.16x118.39%$5.32B
IRTCUSIRhythm
-264.12x71.96%$3.68B
PLSEUSPulse Biosciences
-45.09x27.55%$3.61B
AXGNUSAxogen
-79.20x31.25%$2.66B
BFLYUSButterfly Network
-28.32x34.41%$2.12B
ASSTUSStrive
-2.01x63.26%$1.96B
NVCRUSNovocure
-13.11x2.52%$1.95B
ATECUSAlphatec
-14.43x41.67%$1.59B
DRTSUSAlpha Tau Medical
-15.45x--$1.43B
KMTSUSKestra Medical Tech
-9.52x0.94%$1.43B
TNDMUSTandem Diabetes
-18.93x77.82%$1.20B
IARTUSIntegra LifeSciences
-162.27x109.50%$1.18B
AORTUSArtivion
-364.87x266.67%$1.16B
PRCTUSPROCEPT BioRobotics
-10.16x3.47%$1.12B
ENOVUSEnovis
-0.93x100.97%$1.03B
BBNXUSBeta Bionics
-13.21x16.08%$964.13M
CBLLUSCeribell
-14.54x35.15%$959.45M
AVRUSAnteris Tech Global
-7.92x53.33%$820.60M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.